{
    "nctId": "NCT06309615",
    "briefTitle": "Decision Impact Study of PreciseDx Breast",
    "officialTitle": "Prospective Clinical Utility / Decision Support Study of an AI-enabled Digital Breast Cancer Test (Precise Dx Breast, PDxBRTM) to Predict Early-stage Breast Cancer Recurrence Within 6 Years",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Decision Impact Study of PreciseDx Breast on treating Oncologist",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Invasive breast cancer (ductal / mixed ductal-lobular)\n\nExclusion Criteria:\n\n* Prior history of invasive breast cancer\n* Neoadjuvant therapy",
    "sex": "FEMALE",
    "minimumAge": "23 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}